A Day Up For PDS Biotechnology Corporation

PDS Biotechnology Corporation (PDSB:NASDAQ) rocketted at $11.52, representing a gain of 15.8%. On Thu, Jun 17, 2021, PDSB:NASDAQ touched a New 2-Week Intraday Low of $9.17. The stock appeared on our News Catalysts scanner on Thu, Jun 17, 2021 at 04:59 PM in the 'BIOTECH' category. From Thu, Jun 03, 2021, the stock recorded 70.00% Up Days and 54.55% Green Days

The stock spiked on Fri, Jun 04, 2021 at $13.48 with a volume of 1M+.

About PDS Biotechnology Corporation (PDSB:NASDAQ)

Edge Therapeutics Inc operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. Its core objective lies in the development and commercialization of therapies for serious unmet medical conditions, especially neurological disorders in the hospital setting. The company is currently evaluating EG-1962, its lead product candidate, in the Phase 3 NEWTON 2 study in adult patients with aneurysmal subarachnoid hemorrhage (aSAH). Edge uses its trademark platform known as Precisa, which enables the creation of polymer-based therapeutics capable of delivering directly to the site of injury, without affecting other areas of the body resulting in side-effects.